Same active ingredient, same dose, different delivery system
Two publications by Shaw et al
AARDEX is the only mature, robust and proven adherence solution on the market today, one that maximises the reward, mitigates the risk and delivers resolution for your clinical trial
Taking the injection after this window could result in receiving two doses too close together, potentially increasing the risk of adverse effects such as nausea or vomiting
The Food and Drug Administration on Thursday confirmed that a shortage of Eli Lillys obesity drug tirzepatide has been resolved, a move that will soon put a stop to companies making cheaper copies of the injection
This serum promises to deliver just that, thanks to ingredients like copper peptides, squalane and hyaluronic acid